Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 101

Sort by

Sort Order Select

Journal Articles

Hypomethylating Agent 5-Azacytidine Sensitizes Peripheral T-Cell Lymphoma to SLAMF7-Targeting Therapeutic Antibody, Elotuzumab

Neetha Parameswaran, PhD, Xiaoxian Zhao, PhD, Juraj Bodo, PhD, Lisa Durkin, Yvonne Parker, Daniel Lindner, MD PhD, Eric D. Hsi, MD, Deepa Jagadeesh, MDMPH

Blood (2019) 134 (Supplement_1): 1515.

https://doi.org/10.1182/blood-2019-131800

Published: 2019

Journal Articles

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas

Blood (2019) 133 (22): 2401–2412.

https://doi.org/10.1182/blood.2018889931

Published: 2019

Includes: Supplemental data

Journal Articles

Interferon Regulatory Factor 4 Is a Key Factor in Regulation of T helper Cell Polarization in Graft-Versus-Host Disease

Jochen T Frueh, MSc, BSc, Bushra Rais, PhD, Daniele Yumi Sunaga-Franze, Katja Stein, Sascha Sauer, PhD, Andreas G Chiocchetti, PhD, Michael Lohoff, PhD, Evelyn Ullrich, MD

Blood (2018) 132 (Supplement 1): 3313.

https://doi.org/10.1182/blood-2018-99-116151

Published: 2018

Journal Articles

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Wilhelm G Dirks, PhD, Vivien Hauer, Max Koeppel, PhD, Stefan Nagel, PhD, Michaela Scherr, PhD, Margarete Zaborski, Hans G. Drexler, MD PhD

Blood (2018) 132 (Supplement 1): 5300.

https://doi.org/10.1182/blood-2018-99-110054

Published: 2018

Journal Articles

Microrna-31 Promotes T-Cell Pathogenicity in Chronic Graft-Versus-Host Disease

Yongxia Wu, PhD MD, Mengmeng Zhang, MD, Mohammed Hanief Sofi, PhD MS, Steven Douglas Schutt, BS, David Bastian, Supinya Iamsawat, MSc, Xue-Zhong Yu, MD MS

Blood (2017) 130 (Supplement 1): 3165.

https://doi.org/10.1182/blood.V130.Suppl_1.3165.3165

Published: 2017

Journal Articles

Prdi-BF-1 Strongly Detected in Active Multiple Myeloma By Droplet Digital PCR: A Comparison with Real-Time PCR

Gabriele Buda, PhD MD, Francesca Guerrini, Simone Pacini, Enrico Orciuolo, Sara Galimberti, PhD MD, Mario Petrini, PhD MD Prof

Blood (2017) 130 (Supplement 1): 5373.

https://doi.org/10.1182/blood.V130.Suppl_1.5373.5373

Published: 2017

Journal Articles

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Kentaro Serizawa, Hirokazu Tanaka, MD PhD, Ayano Fukui, MD, Ryosuke Fujiwara, MD, Keigo Sano, MD, Hiroaki Inoue, MD, Takahiro Kumode, MD, Yasuhiro Taniguchi, MD, Yasuyoshi Morita, MD, Luis Espinoza, MDPhD, Itaru Matsumura, MDPhD

Blood (2017) 130 (Supplement 1): 1774.

https://doi.org/10.1182/blood.V130.Suppl_1.1774.1774

Published: 2017

Journal Articles

IL-10 Receptor Deficiency Aggravates Exhaustion of CD8 + T-Cells and Impedes Their Control of Chronic Lymphocytic Leukemia

Bola S Hanna, PhD, Philipp M Röβner, Murat Iskar, PhD, Norman Mack, Verena Kalter, Manfred Schmidt, PhD, Marc Zapatka, PhD, Markus Feuerer, MD, Richard Gabriel, PhD, Peter Lichter, PhD, Martina Seiffert

Blood (2017) 130 (Supplement 1): 385.

https://doi.org/10.1182/blood.V130.Suppl_1.385.385

Published: 2017

Journal Articles

Molecular Characterization of Post-Transplant Plasmablastic Lymphomas Implicates RAS , TP53 , and NOTCH Mutations and MYC Deregulation in Disease Pathogenesis

Rebecca J Leeman-Neill, MDPhD, Patricia M. Raciti, MD, Susan J Hsiao, MD PhD, Murty Vundavalli, PhD, Bachir Alobeid, MD, Mahesh M Mansukhani, MD, Govind Bhagat, MD

Blood (2017) 130 (Supplement 1): 4014.

https://doi.org/10.1182/blood.V130.Suppl_1.4014.4014

Published: 2017

Journal Articles

Correlative Analyses of Cereblon ( CRBN ), cMYC , IRF4 , BLIMP1 , and XBP1 with Clinical Outcomes in Stratus (MM-010), a Phase 3b Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Xiaozhong Qian, Meletios A. Dimopoulos, Michael Amatangelo, PhD, Chad Bjorklund, Katja C. Weisel, Enrique M. Ocio, MDPhD, Xin Yu, Teresa Peluso, Lars Sternas, Mohamed Zaki, Philippe Moreau, MDPhD, Anjan Thakurta, PhD

Blood (2017) 130 (Supplement 1): 3109.

https://doi.org/10.1182/blood.V130.Suppl_1.3109.3109

Published: 2017

Journal Articles

A B-Cell like Phenotype Is Associated with Sensitivity to Venetoclax in Multiple Myeloma

Vikas A. Gupta, MD PhD, Benjamin Barwick, PhD, Scott Newman, PhD, Jonathan J. Keats, PhD, Daniel Auclair, PhD, Shannon Matulis, PhD, Michael R. Rossi, PhD, Ajay K. Nooka, MDMPH, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Lawrence H. Boise, PhD

Blood (2017) 130 (Supplement 1): 3073.

https://doi.org/10.1182/blood.V130.Suppl_1.3073.3073

Published: 2017

Journal Articles

RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators

Alboukadel Kassambara, PhD, Laurie Herviou, Michel Jourdan, Coraline Thibaut, Veronika Vikova, Olivier Elemento, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 4382.

https://doi.org/10.1182/blood.V130.Suppl_1.4382.4382

Published: 2017

Journal Articles

Let's give BACH2 a breath of fresh air

Francesco Bertoni

Blood (2017) 130 (6): 696–697.

https://doi.org/10.1182/blood-2017-06-790402

Published: 2017

Journal Articles

Functional Link Between Heat Shock Protein HSP90alpha and Sirtuin 1 (SIRT1) in the Pathogenesis of Diffuse Large B Cell Lymphoma

Emilia Bialopiotrowicz, PhD, Tomasz Sewastianik, PhD, Monika Noyszewska-Kania, MSc, Maciej Szydlowski, PhD, Ewa Jablonska, PhD, Patryk Gorniak, PhD, Anna Polak, PhD, Przemyslaw Kiliszek, PhD, Krzysztof Warzocha, Przemyslaw Juszczynski, MD PhD

Blood (2016) 128 (22): 4120.

https://doi.org/10.1182/blood.V128.22.4120.4120

Published: 2016

Journal Articles

Transcription Factors and Checkpoint Inhibitor Expression with Age: Markers of Immunosenescence?

Dang Luan, MD, Karen Willard-Gallo, PhD, Soizic Garaud, PhD, Hugues Duvillier, Jean-Nicolas Lodewyckx, Cinzia Solinas, MD, Pushpamali De Silva, Chunyan Gu-Trantien, PhD, Catherine Sibille, MD PhD, Dominique Bron, MD PhD

Blood (2016) 128 (22): 5983.

https://doi.org/10.1182/blood.V128.22.5983.5983

Published: 2016

Journal Articles

Chromatin State Dynamics Underlying CD8 T Cell Differentiation and Dysfunction in Cancer

Mary Philip, MD PhD, Lauren Fairchild, Liping Sun, PhD, Agnes Viale, PhD, Taha Merghoub, PhD, Jedd D. Wolchok, MD PhD, Christina S. Leslie, PhD, Andrea Schietinger, PhD

Blood (2016) 128 (22): 861.

https://doi.org/10.1182/blood.V128.22.861.861

Published: 2016

Journal Articles

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Meirong Zang, Fengyan Jin, Lanting Liu, Gang An, MDPhD, Xiaoqi Qin, MD, Xiaoyan Feng, Yan Xu, MDPhD, Mu Hao, MD PhD, Wen Zhou, PhD, Lugui Qiu, MD PhD

Blood (2015) 126 (23): 2480.

https://doi.org/10.1182/blood.V126.23.2480.2480

Published: 2015

Journal Articles

Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

Niamh Appleby, Ruth Cullen, Dan Painter, Alexandra Smith, Eve Roman, Sharon Barrans, PhD, Sheila J.M. O'Connor, Catherine H Burton, Andrew S Jack, Roger G Owen, Reuben M Tooze, PhD FRCP

Blood (2015) 126 (23): 3924.

https://doi.org/10.1182/blood.V126.23.3924.3924

Published: 2015

Journal Articles

Interfollicular CD10 Expression and Follicular PD1 Tumor-Infiltrating Lymphocytes As Biologic Risk Factors in Patients with Previously Untreated Follicular Lymphoma Receiving Rituximab-Based Biologic Therapy: An Alliance Correlative Science Study (CALGB 50901, 50402, 50701, 50803, 50401)

Aliyah R Sohani, MD, Brandy Pitcher, MS, Amy Chadburn, MD, Jonathan W. Said, MD, Peter Martin, MD, Myron S. Czuczman, MD, Nancy L Bartlett, MD, Cara A. Rosenbaum, MD, John P. Leonard, MD, Bruce D. Cheson, MD, Eric D. Hsi, MD

Blood (2015) 126 (23): 334.

https://doi.org/10.1182/blood.V126.23.334.334

Published: 2015

Journal Articles

Targeting Plasticity and Stemness in Multiple Myeloma Tumor Cells

Stacy W. Blain, PhD, Danielle Joseph, Amitabha Mazumder, MD

Blood (2015) 126 (23): 4270.

https://doi.org/10.1182/blood.V126.23.4270.4270

Published: 2015

NARROW

Hypomethylating Agent 5-Azacytidine Sensitizes Peripheral T-Cell Lymphoma to SLAMF7-Targeting Therapeutic Antibody, Elotuzumab

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas

Interferon Regulatory Factor 4 Is a Key Factor in Regulation of T helper Cell Polarization in Graft-Versus-Host Disease

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Microrna-31 Promotes T-Cell Pathogenicity in Chronic Graft-Versus-Host Disease

Prdi-BF-1 Strongly Detected in Active Multiple Myeloma By Droplet Digital PCR: A Comparison with Real-Time PCR

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

IL-10 Receptor Deficiency Aggravates Exhaustion of CD8 + T-Cells and Impedes Their Control of Chronic Lymphocytic Leukemia

Molecular Characterization of Post-Transplant Plasmablastic Lymphomas Implicates RAS , TP53 , and NOTCH Mutations and MYC Deregulation in Disease Pathogenesis

Correlative Analyses of Cereblon ( CRBN ), cMYC , IRF4 , BLIMP1 , and XBP1 with Clinical Outcomes in Stratus (MM-010), a Phase 3b Study of Pomalidomide (POM) + Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

A B-Cell like Phenotype Is Associated with Sensitivity to Venetoclax in Multiple Myeloma

RNA Sequencing Data-Driven Dissection of Human Plasma Cell Differentiation Reveals New Potential Transcription Regulators

Let's give BACH2 a breath of fresh air

Functional Link Between Heat Shock Protein HSP90alpha and Sirtuin 1 (SIRT1) in the Pathogenesis of Diffuse Large B Cell Lymphoma

Transcription Factors and Checkpoint Inhibitor Expression with Age: Markers of Immunosenescence?

Chromatin State Dynamics Underlying CD8 T Cell Differentiation and Dysfunction in Cancer

Suppression of Cdc37 Induces Bortezomib Resistance through Autophagy Activation and Plasma Cell Immaturation in Multiple Myeloma

Poor Outcomes in HIV Negative and HIV Positive Patients with Plasmablastic Lymphoma (PBL) in a Population Based Patient Study

Interfollicular CD10 Expression and Follicular PD1 Tumor-Infiltrating Lymphocytes As Biologic Risk Factors in Patients with Previously Untreated Follicular Lymphoma Receiving Rituximab-Based Biologic Therapy: An Alliance Correlative Science Study (CALGB 50901, 50402, 50701, 50803, 50401)

Targeting Plasticity and Stemness in Multiple Myeloma Tumor Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only